195 related articles for article (PubMed ID: 10688111)
1. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
Bergström M; Bonasera TA; Lu L; Bergström E; Backlin C; Juhlin C; Långström B
J Nucl Med; 1998 Jun; 39(6):982-9. PubMed ID: 9627330
[TBL] [Abstract][Full Text] [Related]
3. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
4. 11C-metomidate PET imaging of adrenocortical cancer.
Khan TS; Sundin A; Juhlin C; Långström B; Bergström M; Eriksson B
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):403-10. PubMed ID: 12634969
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
6. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Gross MD; Shapiro B; Kloos RT; Dwamena B
J Nucl Med; 2000 Nov; 41(11):1933-4. PubMed ID: 11079507
[No Abstract] [Full Text] [Related]
7. The role of PET in localization of neuroendocrine and adrenocortical tumors.
Eriksson B; Bergström M; Sundin A; Juhlin C; Orlefors H; Oberg K; Långström B
Ann N Y Acad Sci; 2002 Sep; 970():159-69. PubMed ID: 12381551
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate].
Juhlin C; Törnblom S; Rastad J; Bergström M; Bonasera T; Sundin A; Långström B
Nord Med; 1998 Nov; 113(9):306-7. PubMed ID: 9835764
[TBL] [Abstract][Full Text] [Related]
10. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
11. Metomidate-based imaging of adrenal masses.
Hahner S; Sundin A
Horm Cancer; 2011 Dec; 2(6):348-53. PubMed ID: 22124841
[TBL] [Abstract][Full Text] [Related]
12. [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.
Hahner S; Stuermer A; Kreissl M; Reiners C; Fassnacht M; Haenscheid H; Beuschlein F; Zink M; Lang K; Allolio B; Schirbel A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2358-65. PubMed ID: 18397978
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three different purification methods for the routine preparation of [11C] Metomidate.
Mitterhauser M; Wadsak W; Langer O; Schmaljohann J; Zettinig G; Dudczak R; Viernstein H; Kletter K
Appl Radiat Isot; 2003; 59(2-3):125-8. PubMed ID: 12941500
[TBL] [Abstract][Full Text] [Related]
15. 11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman With Congenital Adrenal Hyperplasia.
Burman P; Falhammar H; Waldenström E; Sundin A; Bitzén U
J Clin Endocrinol Metab; 2021 Jan; 106(2):e675-e679. PubMed ID: 33245336
[TBL] [Abstract][Full Text] [Related]
16. [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Kreissl MC; Schirbel A; Fassnacht M; Haenscheid H; Verburg FA; Bock S; Saeger W; Knoedler P; Reiners C; Buck AK; Allolio B; Hahner S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2755-64. PubMed ID: 23609836
[TBL] [Abstract][Full Text] [Related]
17. Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography.
Razifar P; Hennings J; Monazzam A; Hellman P; Långström B; Sundin A
BMC Med Imaging; 2009 Apr; 9():6. PubMed ID: 19386097
[TBL] [Abstract][Full Text] [Related]
18. Development of [
Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
[TBL] [Abstract][Full Text] [Related]
19.
Chen Cardenas SM; Santhanam P
Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT.
Hahner S; Kreissl MC; Fassnacht M; Haenscheid H; Bock S; Verburg FA; Knoedler P; Lang K; Reiners C; Buck AK; Allolio B; Schirbel A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1508-18. PubMed ID: 23426614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
